We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
7 November 2019
EraCal Therapeutics AG, established as a spin-off from the University of Zurich and Harvard University, completes an oversubscribed seed financing round. Investors included Bernina BioInvest, Redalpine, the UZH Life Sciences Fund and private investors. The seed capital will be used to advance the preclinical development of Era-107, an appetite modulator that has a more specific effect than previous drugs and therefore causes fewer side effects. VISCHER acts as legal advisor to EraCal Therapeutics AG in the seed financing round. The VISCHER team includes Christian Wyss (Partner, Corporate / M&A), Luzius Zumstein (Associate, Corporate / M&A), Dr. Sara Ianni (Associate, Corporate / M&A), and Adrian Briner (Associate, Tax).
Press release
Categories: Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk, Deals & Cases
Attorney at Law
Swiss Certified Public Accountant, Swiss Certified Tax Expert
The German energy supplier EnBW enters into a partnership with narrowin GmbH, a Swiss cybersecurity...
EraCal Therapeutics AG ("EraCal"), a Swiss biotech start-up company focusing on the fight of obesity...
T3 Pharmaceuticals AG, a biotechnology company with its headquarter in Allschwil, Switzerland has...